Jiangsu
China
8
2021-06-17
8
2023-10-24
These are the the leading inventors for applications assigned to DINGFU BIOTARGET CO., LTD.:
DINGFU BIOTARGET CO., LTD. based in Jiangsu, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Anti-CD27 antibodies and use thereof
#2 | 2021-06-03 ✅ Patent 11,529,425 granted on 2022-12-20Immunoconjugates comprising signal regulatory protein alpha
#3 | 2020-11-12 ✅ Patent 11,845,806 granted on 2023-12-19Proteinaceous heterodimer and use thereof
#4 | 2020-09-03 ✅ Patent 11,987,609 granted on 2024-05-21Proteinaceous heterodimer and use thereof
#5 | 2020-08-27 ✅ Patent 11,883,503 granted on 2024-01-30Methods and compositions for cancer treatment
#6 | 2020-03-05 ✅ Patent 11,357,826 granted on 2022-06-14IL-10 EGFR antibody fusion protein and uses thereof
#7 | 2018-10-04 ✅ Patent 10,875,926 granted on 2020-12-29Fully human antibody against human CD 137
#8 | 2017-11-30 ✅ Patent 10,471,124 granted on 2019-11-12Proteinaceous heterodimer and use thereof
Also check out DINGFU BIOTARGET CO., LTD.'s (Jiangsu, China) applicant profile with 6 patent applications submitted.
165217 ⎘